Coxsackievirus B RNA replication: lessons from poliovirus
- PMID: 18357767
- DOI: 10.1007/978-3-540-75546-3_5
Coxsackievirus B RNA replication: lessons from poliovirus
Abstract
The replication of coxsackievirus RNA occurs with rapid onset, starting approximately 2.5 h after infection. The mechanisms entailing the RNA replication of enteroviruses, like coxsackievirus and poliovirus, are highly conserved. These processes require two steps of RNA amplification: (i) complete synthesis of the negative-strand RNA using input RNA as the template and (ii) synthesis of the positive-strand RNA using the intermediate negative-strand RNA as the template. Successful enterovirus RNA replication requires all of the viral nonstructural proteins in their mature and precursor forms, as well as RNA secondary structures in the template. The encoded nonstructural proteins are responsible for RNA replication through multiple protein-protein interactions between viral and/or host proteins to mediate RNA synthesis, induce membranous vesicles, and deliver the replication complex to the template. The RNA secondary structures at the 5' and 3' termini of the template position the RNA replication complex at the initiation site(s) for both negative- and positive-strand RNA synthesis, thus providing binding sites for viral and host proteins that may functionally circularize the genome during RNA synthesis. Although considerable knowledge has been gained regarding the mechanism of enterovirus RNA synthesis, the complete steps in RNA replication have not been fully determined. The aim of this review is to summarize the current state of our knowledge and to present a model that encompasses the identified steps of enterovirus RNA replication.
Similar articles
-
Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.mBio. 2018 Sep 4;9(5):e01669-18. doi: 10.1128/mBio.01669-18. mBio. 2018. PMID: 30181254 Free PMC article.
-
Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity.Virology. 2009 Jun 20;389(1-2):45-58. doi: 10.1016/j.virol.2009.03.012. Epub 2009 May 14. Virology. 2009. PMID: 19446305 Free PMC article.
-
Cellular Protein HuR Regulates the Switching of Genomic RNA Templates for Differential Functions during the Coxsackievirus B3 Life Cycle.J Virol. 2021 Oct 13;95(21):e0091521. doi: 10.1128/JVI.00915-21. Epub 2021 Aug 18. J Virol. 2021. PMID: 34406862 Free PMC article.
-
CVB translation: lessons from the polioviruses.Curr Top Microbiol Immunol. 2008;323:123-47. doi: 10.1007/978-3-540-75546-3_6. Curr Top Microbiol Immunol. 2008. PMID: 18357768 Review.
-
Structures and Functions of Viral 5' Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections.Viruses. 2020 Aug 21;12(9):919. doi: 10.3390/v12090919. Viruses. 2020. PMID: 32839386 Free PMC article. Review.
Cited by
-
Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.J Virol. 2017 Jul 27;91(16):e00423-17. doi: 10.1128/JVI.00423-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28539455 Free PMC article.
-
Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.J Virol. 2015 Dec;89(23):11761-72. doi: 10.1128/JVI.01308-15. Epub 2015 Sep 9. J Virol. 2015. PMID: 26355088 Free PMC article.
-
The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases.J Virol. 2008 Oct;82(19):9577-90. doi: 10.1128/JVI.00631-08. Epub 2008 Jul 16. J Virol. 2008. PMID: 18632861 Free PMC article.
-
EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication.J Virol. 2013 Jun;87(12):6625-34. doi: 10.1128/JVI.01006-12. Epub 2013 Apr 3. J Virol. 2013. PMID: 23552423 Free PMC article.
-
GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.J Cell Physiol. 2015 Oct;230(10):2552-78. doi: 10.1002/jcp.25014. J Cell Physiol. 2015. PMID: 25858032 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources